Morocco recovered from Cody Gakpo's opener to beat Netherlands on penalties in a gripping Round of 32 tie. Morocco booked their place in the FIFA World Cup 2026™ Round of 16 after edging past ...

Game summary of the Racing (Montevideo) vs. Progreso Liga Auf Uruguaya game, final score 0-0, from September 29, 2025 on ESPN.

Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

FIFA WORLD CUP 2026 How to watch today’s World Cup matches: Monday, June 29 Today's matches are Brazil vs Japan, Germany vs Paraguay, and the Netherlands vs Morocco.

5月25日，据界面新闻，柒和伊控股5月25日发布正式讣告，前董事长兼CEO铃木敏文因心力衰竭于5月18日逝世，终年93岁。 作为日本“零售之神”，他于上个世纪70年代将7-Eleven引入日本并实现反向收购，成功缔造了庞大的全球零售帝国。柒和伊控股表示，遵照家属 ...

Please provide your email address to receive an email when new articles are posted on . Ixekizumab plus tirzepatide improved skin clearance and body weight in people with difficult-to-treat psoriasis ...

There's probably a lot of you gamers out there on older graphics card pondering an upgrade. Is it worth it? Or is it a waste of money? Well, in an attempt to answer that question for a fair few of you ...

Abstract: Concrete compressive strength is a critical parameter influencing the structural integrity, safety and durability of buildings. This study proposes a data-driven framework to predict ...

Among patients with psoriasis who switched to guselkumab, treatment persistence was 190%, 78%, and 187% more likely at 12 months compared with those who switched to tumor necrosis factor inhibitors, ...

Bimekizumab is associated with significant improvements in pruritus, skin pain, scaling, skin clearance, and quality of life through 3 years of treatment in those with plaque psoriasis. Bimekizumab ...

Please provide your email address to receive an email when new articles are posted on . Two phase 3 studies evaluated efficacy and safety of zasocitinib for plaque psoriasis. About 70% of participants ...

DENVER -- Adding a GLP-1 agonist to psoriasis medication significantly improved outcomes in patients with psoriatic arthritis (PsA) and overweight or obesity, a phase III randomized trial showed.